Skip to Content

E126 (Letrozole 2.5 mg)

Pill with imprint E126 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Qualitest Pharmaceuticals.

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for E126

Letrozole 2.5 mg E126

Letrozole

Imprint:
E126
Strength:
2.5 mg
Color:
Yellow
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Qualitest Pharmaceuticals
National Drug Code (NDC):
00603-4180
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide